Utility of C-reactive Protein-to-Albumin and Uric Acid-to-Albumin Ratios for Assessing Coronary Artery Disease Severity in Acute Coronary Syndrome: A Study From a Major Tertiary Care Center in Northeast India

C反应蛋白/白蛋白比值和尿酸/白蛋白比值在评估急性冠脉综合征患者冠状动脉疾病严重程度中的应用:一项来自印度东北部一家大型三级医疗中心的研究

阅读:1

Abstract

INTRODUCTION: Inflammation plays a crucial role in the pathophysiology of acute coronary syndrome (ACS). The C-reactive protein-to-albumin ratio (CAR) and uric acid-to-albumin ratio (UAR) are novel markers of systemic inflammation, and their clinical significance has not been elucidated in ACS. AIM: This study aims to evaluate the association between CAR and UAR with the severity of coronary artery disease (CAD) in patients with ACS undergoing coronary angiography, as assessed by the SYNTAX score (SS). MATERIALS AND METHODS: This is a hospital-based cross-sectional study conducted from November 2021 to October 2022. A total of 233 patients with ACS were enrolled in the study, who underwent relevant investigations. Coronary angiograms were used to diagnose the presence of CAD, and its severity was assessed using SS. The correlation between UAR and CAR with CAD severity, as measured by SS, was studied and compared in the study population. RESULTS: The mean age of the study population was 57.17 ± 10.40 years, with average CAR and UAR values of 8.55 ± 11.05 and 1.62 ± 0.47, respectively. Pearson's correlation analysis showed significant positive correlations between CAR and SS (r = 0.779, p < 0.001) and between UAR and SS (r = 0.823, p < 0.001). Univariable logistic regression analysis indicated that C-reactive protein, serum uric acid, UAR, and CAR were significantly associated with an intermediate to high SS (p < 0.001). CONCLUSION: The present study demonstrated a significant association between CAR and UAR with the severity of CAD, as assessed by SS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。